Semaglutide has emerged as a promising treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and suppressing https://janefpij839952.ja-blog.com/35789298/understanding-semaglutide-a-comprehensive-guide